Time to Evolve: Predicting engineered T cell toxicity with next gen. models

ART-TG contributed to this recent review by Donnadieu et al. in Journal for Immunotherapy of Cancer, https://jitc.bmj.com/content/10/5/e003486.long as part of the T2Evolve european consortium https://t2evolve.com/.

#genetherapy, #cartcells, #T2Evolve, #genopole, #inserm, #upsay